Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication?

Journal of Gastroenterology

Volumn 37, Issue 6, 2002, Pages 428-433

  Matsushima, Yumi ^a,d   Kinoshita, Yoshikazu ^d,e   Fukui, Hirokazu ^d,f   Maekawa, Toru ^a,d   Yazumi, Shujiro ^a,d   Okada, Akihiko ^a,d   Nakase, Hiroshi ^d,f   Kawanami, Chiharu ^a,d   Iwano, Masahiro ^b,d   Hashimoto, Kimio ^c,d   Takeda, Zenju ^b,d   Okazaki, Kazuichi ^d,f   Chiba, Tsutomu ^a,d  

^a KOBE UNIVERSITY   (Japan)

^b YODOGAWA CHRISTIAN HOSPITAL   (Japan)

^c NISHI KOBE MEDICAL CENTER   (Japan)

^d Department of Orthopaedics   (Japan)

^e SHIMANE UNIVERSITY   (Japan)

^f KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Eradication therapy; Flow cytometry; Helicobacter pylori; MALT lymphoma

Indexed keywords

AMOXICILLIN; BIOLOGICAL MARKER; CD19 ANTIGEN; CD20 ANTIGEN; CLARITHROMYCIN; INTERLEUKIN 2 RECEPTOR; PROTON PUMP INHIBITOR; IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER GRADING; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DETERIORATION; DIAGNOSTIC VALUE; ERADICATION THERAPY; FEMALE; FLOW CYTOMETRY; GASTRECTOMY; GENE REARRANGEMENT; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN GENE; IMMUNOLOGY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SOUTHERN BLOTTING; STOMACH LYMPHOMA; BLOOD; GENETICS; HELICOBACTER INFECTION; MICROBIOLOGY; MIDDLE AGED; REMISSION; STOMACH TUMOR; TREATMENT OUTCOME;

ANTIGENS, CD19; ANTIGENS, CD20; B-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; GASTRECTOMY; GENE REARRANGEMENT; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; IMMUNOGLOBULINS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; MIDDLE AGE; PROGNOSIS; RECEPTORS, INTERLEUKIN-2; REMISSION INDUCTION; STOMACH NEOPLASMS; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME; HUMANS; MIDDLE AGED;

EID: 0035990088     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350200062     Document Type: Article

References (21)

1. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma
2. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
3. Regression of primary gastric lymphoma of mucosa-Associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group
4. Progression of gastritis to monoclonal B-cell lymphoma with resolution and recurrence following eradication of Helicobacter pylori
5. Gastrointestinal lymphoma
6. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma. Clinicopathological study and evaluation of the prognostic factors in 143 patients
7. Primary gastric non-Hodgkin's lymphoma: A clinicopathological study of 41 patients
8. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging
9. Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma
10. Lymphocyte subsets in human thymoma studied with monoclonal antibodies
11. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro
12. In vivo and in vitro expression of an interleukin 2 receptor by murine B and T Lymphocytes
13. Structural analysis of recombinant soluble human interleukin-2 receptor. Primary structure, assignment of disulfide bonds and core IL-2 binding structure
14. The released interleukin 2 receptor binds interleukin 2 efficiently
15. Increased levels of soluble interleukin-2 receptor in non-Hodgkin's lymphomas. Relationship with clinical, histologic, and phenotypic features
16. Clinical implications of cytokine and soluble receptor measurements in patients with newly diagnosed aggressive non-Hodgkin's lymphoma
17. Helicobacter pylori and the t(11;18) (q2l;q2t) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type
18. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy
19. AP12-MALT1 Chimeric transcript is a predictive marker for the responsiveness of H. pylori eradication treatment in low-grade gastric MALT lymphoma